Know Cancer

forgot password

Using Biploar Technology for Transurethral Resection of Bladder Tumor - a Randomized Controlled Trial

Phase 3
18 Years
Open (Enrolling)
Urinary Bladder Tumor

Thank you

Trial Information

Using Biploar Technology for Transurethral Resection of Bladder Tumor - a Randomized Controlled Trial

Transurethral resection (TUR) of bladder tumor is one of commonest procedures in urology
practice. It is the surgery of choice for staging and treating non-muscle invasive bladder
cancer. Short lengths of hospital stay, simple and safe are the main advantages of the
surgery. Conventional TUR is performed with monopolar diathermy, which commonly elicits
obturator reflexes in lateral-located tumor. However, it is not without complication.
Bleeding and bladder perforation with or without obturator reflex are the most significant
complications after TUR of bladder tumor. The charring effect of monopolar is also a concern
as the diagnosis of muscle invasion by tumor is determined by the integrity of tumor base
biopsy. Mariappan et al. reported that as high as 33% of the specimen had no detrusor muscle
present for assessment. The absent of muscle not only affect the staging procedure but also
associated with higher cancer recurrence rate.

Bipolar resection has been widely used in transurethral resection of prostate (TURP). As
compared with the traditional monopolar technology, the electric current passes through the
instrument sheath. The advantage of bipolar technology includes less obturator reflex, good
hemostasis and early recovery. Study has showed that the cautery artifact is more severe on
monopolar resection as compared with bipolar in prostate tissues. Due to the clean and
precise cutting, there will be less charring on the specimen and thermal injury to
peripheral tissues. Applying to bladder tumor resection, this will improve the staging
accuracy with better determination of the depth of invasion. Furthermore, with the use of
saline instead of glycine as irrigation fluid, risk of TUR syndrome is minimized. There is
no randomized trial on the benefit of using bipolar instrument on TUR bladder cancer. In
this study, investigator will investigate the role of bipolar technology in TUR bladder
cancer as compared with traditional monopolar resection.

Inclusion Criteria:

- Adult male or female patients (age ≥ 18)

- Patients who have diagnosed with bladder cancer (either primary or recurrent) by

Exclusion Criteria:

- Patients who are scheduled for second TUR within 6 weeks after the previous TUR

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

Muscle sampling rate

Outcome Description:

To assess the charring effect to the integrity of the tumor base biopsy

Outcome Time Frame:

An expected average of 7 days post operation

Safety Issue:


Principal Investigator

Eddie SY Chan, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Chinese University of Hong Kong


Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee

Study ID:




Start Date:

May 2012

Completion Date:

July 2014

Related Keywords:

  • Urinary Bladder Tumor
  • urinary bladder tumor
  • monopolar TURBT
  • bipolar TURBT
  • Urinary Bladder Neoplasms